Vantage Health Inc, (OTCQB: VNTH) and its parent company Nanobeak Inc. today announced that they have formed a strategic partnership with Scripps Translational Science Institute (STSI) for the advancement of mobile health technology.
 
Vantage Health is developing personalized and point-of-care screening using Apps based upon chemical sensing residing within a small device attached to a smartphone.